Grants per year
Personal profile
Research Interests
Pediatric Pathology
Wilms tumors, germ cell tumors, genitourinary development
Certifications and Licenses
| Pediatric Pathology | |
| Anatomic Pathology |
Training Experience
| 1990 | Fellowship, Johns Hopkins Hospital |
| 1990 | Residency, Johns Hopkins Hospital |
Education/Academic qualification
MD, Johns Hopkins University
… → 1984
Research interests
- Pathology
Fingerprint Dive into the research topics where Elizabeth J Perlman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 9 Similar Profiles
Wilms Tumor
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Kidney
Medicine & Life Sciences
Pediatrics
Medicine & Life Sciences
Germ Cell and Embryonal Neoplasms
Medicine & Life Sciences
Histology
Medicine & Life Sciences
Comparative Genomic Hybridization
Medicine & Life Sciences
Clear Cell Sarcoma
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants 2012 2019
- 7 Finished
Embryonic renal tumors: a model for epigenetic transcription regulation in early stem cells
Galat, V., Perlman, E. J. & Topczewski, J.
Northwestern University, IDP Foundation
3/1/15 → 8/31/16
Project: Research project
Committee Leadership: NIH National Clinical Trials Network (NCTN) Grant
Children's Hospital of Philadelphia, National Cancer Institute
4/11/14 → 2/28/19
Project: Research project
1q gain to stratify favorable histology Wilms tumor
Collaborative Pediatric Cancer Research Awards Program
4/1/14 → 9/30/15
Project: Research project
COG Work Order Pathology Review: NIH COG Chair Grant (U10CA098543)
Children's Hospital of Philadelphia, National Cancer Institute
3/1/14 → 2/28/19
Project: Research project
Research Output 1987 2019
1
Citation
(Scopus)
Augmentation of therapy for combined loss of heterozygosity 1p and 16q in favorable histology wilms tumor: A Children's Oncology Group AREN0532 and AREN0533 study report
behalf of the AREN0532 and AREN0533 study committees., Jan 1 2019, In : Journal of Clinical Oncology. 37, 30, p. 2769-2777 9 p.Research output: Contribution to journal › Article
Wilms Tumor
Loss of Heterozygosity
Histology
Disease-Free Survival
Chromosomes
3
Citations
(Scopus)
Impact of cyclophosphamide and etoposide on outcome of clear cell sarcoma of the kidney treated on the National Wilms Tumor Study-5 (NWTS-5)
Seibel, N. L., Chi, Y. Y., Perlman, E. J., Tian, J., Sun, J., Anderson, J. R., Ritchey, M. L., Thomas, P. R., Miser, J., Kalapurakal, J. A., Grundy, P. E. & Green, D. M., Jan 2019, In : Pediatric Blood and Cancer. 66, 1, e27450.Research output: Contribution to journal › Article
Clear Cell Sarcoma
Etoposide
Cyclophosphamide
Kidney
Disease-Free Survival
1
Citation
(Scopus)
Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms’ tumor
Ortiz, M. V., Ahmed, S., Burns, M., Henssen, A. G., Hollmann, T. J., MacArthur, I., Gunasekera, S., Gaewsky, L., Bradwin, G., Ryan, J., Letai, A., He, Y., Naranjo, A., Chi, Y. Y., LaQuaglia, M., Heaton, T., Cifani, P., Dome, J. S., Gadd, S., Perlman, E. & 3 others, , Aug 8 2019, In : JCI Insight. 4, 15, e127098.Research output: Contribution to journal › Article
Open Access
Wilms Tumor
Drug Therapy
Urine
Therapeutics
Kidney
3
Citations
(Scopus)
Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 study
AREN0321 Study Committee, Sep 2019, In : European Journal of Cancer. 118, p. 58-66 9 p.Research output: Contribution to journal › Article
Wilms Tumor
Doxorubicin
Radiation
Disease-Free Survival
Dactinomycin
3
Citations
(Scopus)
A unique subset of low-risk wilms tumors is characterized by loss of function of TRIM28 (KAP1), a gene critical in early renal development: A children’s oncology group study
Armstrong, A. E., Gadd, S., Huff, V., Gerhard, D. S., Dome, J. S. & Perlman, E. J., Dec 2018, In : PloS one. 13, 12, e0208936.Research output: Contribution to journal › Article
Oncology
Wilms Tumor
Set theory
Tumors
Genes